Results 141 to 150 of about 4,399 (180)
Some of the next articles are maybe not open access.
Molecular Control of Megakaryopoiesis and Thrombopoiesis
International Journal of Hematology, 2002Megakaryopoiesis and subsequent thrombopoiesis occur through complex biologic steps: megakaryocyte precursors that developed from hematopoietic stem cells initially proliferate, then differentiate into mature polyploid megakaryocytes, and finally release platelets.
Itaru, Matsumura, Yuzuru, Kanakura
openaire +2 more sources
Pathologic thrombopoiesis of rheumatoid arthritis
Rheumatology International, 2003Rheumatoid arthritis (RA) is frequently complicated by thrombocytosis correlated with disease activity. The exact pathogenetic mechanism(s) that cause increased platelet counts in RA are still unknown. Recent investigations indicate that proinflammatory pleiotropic cytokines of RA also have megakaryocytopoietic/thrombopoietic properties.
Celik, I +5 more
openaire +3 more sources
Megakaryopoiesis and Thrombopoiesis
2017Platelets are formed from the cytoplasm of megakaryocytes (MKs) that reside in the bone marrow (BM). MKs arise from hematopoietic stem cells in the osteoblastic niche in BM. The primary regulator of megakaryopoiesis is thrombopoietin. It is generally accepted that MKs migrate into the vascular niche and produce platelets; however, the mechanism by ...
Shugo Kowata, Yoji Ishida
openaire +1 more source
Megakaryocytes and Thrombopoiesis
Journal of thrombosis and haemostasis, 2009http://onlinelibrary.wiley.com/doi/10.1111/jth.2009.7.issue-s2 ...
Hartwig, John H +5 more
openaire +2 more sources
Transcriptional Regulation of Thrombopoiesis.
Blood, 2008Abstract Over the past two decades, a number of key transcription factors have been identified that play essential roles in megakaryocyte development. These include GATA-1, GATA-2, Friend of GATA-1 (FOG-1), Runx-1, Cbf-β, Fli-1, GABPα, TEL, NF-E2 p45, Gfi-1b, and SCL/TAL.
Alan B. Cantor +7 more
openaire +1 more source
Blood, 2010
Abstract Abstract 1609 Background. The mechanisms that regulate megakaryocytic (Mk) development within the bone marrow environment remain poorly understood. The underlying relationships between Mk maturation and bone marrow components are key factors in this process.
Isabella Pallotta +3 more
openaire +1 more source
Abstract Abstract 1609 Background. The mechanisms that regulate megakaryocytic (Mk) development within the bone marrow environment remain poorly understood. The underlying relationships between Mk maturation and bone marrow components are key factors in this process.
Isabella Pallotta +3 more
openaire +1 more source
Thrombopoietins and Thrombopoiesis: A Clinical Perspective
Vox Sanguinis, 1998AbstractSince the discovery of thrombopoietin four years ago there has been much interest in the clinical use of this growth factor and its impact on platelet transfusions. Two recombinant thrombopoietin molecules are currently under intense clinical investigation.
openaire +2 more sources
Mechanisms of embryonic thrombopoiesis
2021Platelets are generated by specialized cells called megakaryocytes (MKs) throughout embryonic development and adulthood. In adult bone marrow, MKs form and release proplatelets into circulation which mature into functional peripheral platelets. However, platelet generation in embryos is not fully understood. This is due to limitations of existing mouse
openaire +1 more source
Thrombopoietin: a tool for understanding thrombopoiesis
Journal of Thrombosis and Haemostasis, 2003Although first proposed to be the primary regulator of platelet production 45 years ago, the gene for thrombopoietin was cloned only within the last decade. Since then, our understanding of megakaryocyte and platelet production has increased substantially, and it is now appreciated that in addition to its critical role in regulating thrombopoiesis, the
openaire +2 more sources
Humoral control of thrombopoiesis.
Blood cells, 1981There is increasing evidence that an important mechanism by which platelet production is regulated depends upon a humoral substance (thrombopoietin) that affects the production of platelets by megakaryocytes. Plasma from thrombocytopenic donors increases the rate of appearance or concentrations of subsequently administered Na235SO4 or selenomethionine ...
J, Levin, B L, Evatt
openaire +1 more source

